Investigators have examined how various symptoms experienced by individuals with kidney failure are impacted by kidney transplantation. The findings will appear in an upcoming issue of CJASN.
Jun 19, 2021
0
1
A new analysis reveals that may individuals with kidney failure who are most likely to benefit from kidney transplants are not being expeditiously placed on the transplant waiting list in the United States. The analysis, ...
Jun 17, 2021
0
1
Pneumocystis jirovecii is a fungal infection that causes pneumonia, often in highly immunocompromised patients, such as those recently undergoing transplants. Before 2019, Marwan Azar, MD, FAST, and his colleagues in Internal ...
Jun 17, 2021
0
2
In a study of more than 10,600 adult patients hospitalized with COVID-19, women had significantly lower odds than men of in-hospital mortality. They also had fewer admissions to the intensive care unit and less need for mechanical ...
Jun 16, 2021
0
0
Individuals with kidney failure who receive dialysis treatments in clinics (called in-center dialysis) are especially vulnerable to COVID-19, with death rates reported at over 20% in recent studies; however, there has been ...
Jun 9, 2021
0
3
Alphonso Harried recently came across a newspaper clipping about his grandfather receiving his 1,000th dialysis treatment. His grandfather later died—at a dialysis center—as did his uncle, both from kidney disease.
Jun 9, 2021
0
2
In an analysis of patients on hemodialysis in New York City, there were substantial racial/ethnic disparities in COVID-19 rates that were not explained by neighborhood social vulnerability. The findings appear in an upcoming ...
Jun 4, 2021
0
1
Many individuals with kidney failure have been unable to self-isolate during the COVID-19 pandemic because they require dialysis treatments in clinics several times a week. New research that will appear in an upcoming issue ...
Jun 2, 2021
0
4
Patients with chronic kidney disease and Type 2 diabetes who took the experimental drug finerenone were about 30% less likely to develop the heart rhythm disorder atrial fibrillation (AFib) than those taking a placebo, according ...
May 17, 2021
0
2
Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not significantly reduce the risk of organ failure or death or improve recovery in patients hospitalized with COVID-19 who are at high risk of developing ...
May 17, 2021
0
3
